Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Previously Untreated Marginal Zone Lymphoma

This study is currently recruiting participants.

Verified April 2013 by University of Miami Sylvester Comprehensive Cancer Center

Study NCT00453102 Information provided by University of Miami Sylvester Comprehensive Cancer Center

First Received on March 27, 2007. Last Updated on April 18, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Lymphoma

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

Rituximab
Ibritumomab Tiuxetan

Additional drug interventions recognized in this trial

More general drug interventions related to this trial

Sponsors listed in this trial